Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BETAXOLOL vs BEVACIZUMAB-MALY: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BETAXOLOL vs BEVACIZUMAB-MALY: Safety Overview

Metric BETAXOLOL BEVACIZUMAB-MALY
Total FAERS Reports 638 121
Deaths Reported 67 20
Death Rate 10.5% 16.5%
Hospitalizations 261 28
Average Patient Age 67.3 yrs 62.6 yrs
% Female Patients 63.7% 49.3%
FDA Approval Date Apr 12, 2001 N/A
Manufacturer Novartis Pharmaceuticals Corporation Valorum Biologics, LLC
Route OPHTHALMIC INTRAVENOUS
Marketing Status Prescription Prescription